Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients.

Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M.

J Alzheimers Dis. 2006 Sep;10(1):1-7.

PMID:
16988474
2.
3.

Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients.

Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F, Bernard G.

J Alzheimers Dis. 2005 Jun;7(3):221-32; discussion 255-62.

PMID:
16006665
4.

Immune blood biomarkers of Alzheimer disease patients.

Avagyan H, Goldenson B, Tse E, Masoumi A, Porter V, Wiedau-Pazos M, Sayre J, Ong R, Mahanian M, Koo P, Bae S, Micic M, Liu PT, Rosenthal MJ, Fiala M.

J Neuroimmunol. 2009 May 29;210(1-2):67-72. doi: 10.1016/j.jneuroim.2009.02.015. Epub 2009 Mar 28.

PMID:
19329192
5.

Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.

Zaghi J, Goldenson B, Inayathullah M, Lossinsky AS, Masoumi A, Avagyan H, Mahanian M, Bernas M, Weinand M, Rosenthal MJ, Espinosa-Jeffrey A, de Vellis J, Teplow DB, Fiala M.

Acta Neuropathol. 2009 Feb;117(2):111-24. doi: 10.1007/s00401-008-0481-0. Epub 2009 Jan 13.

6.

1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients.

Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwickie M, Cashman J, Fiala M.

J Alzheimers Dis. 2009;17(3):703-17. doi: 10.3233/JAD-2009-1080.

PMID:
19433889
7.

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC.

Brain. 2007 Nov;130(Pt 11):2837-44. Epub 2007 Oct 10.

PMID:
17928318
8.

Plasma biomarkers of Alzheimer's disease.

Kawarabayashi T, Shoji M.

Curr Opin Psychiatry. 2008 May;21(3):260-7. doi: 10.1097/YCO.0b013e3282fc989f. Review.

PMID:
18382225
9.

Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.

Baranowska-Bik A, Bik W, Wolinska-Witort E, Martynska L, Chmielowska M, Barcikowska M, Baranowska B.

Neuro Endocrinol Lett. 2008 Feb;29(1):75-9.

PMID:
18283248
10.

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, Chiang B, Hui J, Mahanian M, Baghaee A, Hong P, Cashman J.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12849-54. Epub 2007 Jul 24.

11.

Kinetic analysis of aggregated amyloid-beta peptide clearance in adult bone-marrow-derived macrophages from APP and CCL2 transgenic mice.

Yamamoto M, Kiyota T, Walsh SM, Ikezu T.

J Neuroimmune Pharmacol. 2007 Jun;2(2):213-21. Epub 2006 Dec 5.

PMID:
18040846
12.

Abeta amyloid deposition in the language system and how the brain responds.

Nelissen N, Vandenbulcke M, Fannes K, Verbruggen A, Peeters R, Dupont P, Van Laere K, Bormans G, Vandenberghe R.

Brain. 2007 Aug;130(Pt 8):2055-69. Epub 2007 Jun 24.

PMID:
17586869
13.

Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.

Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.

Glia. 2008 Jan 15;56(2):154-63.

PMID:
18004725
14.

Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to β-amyloid clearance.

Gagliardi S, Ghirmai S, Abel KJ, Lanier M, Gardai SJ, Lee C, Cashman JR.

Chem Res Toxicol. 2012 Jan 13;25(1):101-12. doi: 10.1021/tx200246t. Epub 2011 Nov 7.

PMID:
22029407
15.

Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.

Verwey NA, Schuitemaker A, van der Flier WM, Mulder SD, Mulder C, Hack CE, Scheltens P, Blankenstein MA, Veerhuis R.

Dement Geriatr Cogn Disord. 2008;26(6):522-7. doi: 10.1159/000178756. Epub 2008 Dec 2. Erratum in: Dement Geriatr Cogn Disord. 2009;27(6):584.

PMID:
19052452
16.

Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets.

Shi C, Guo K, Yew DT, Yao Z, Forster EL, Wang H, Xu J.

Exp Gerontol. 2008 Jun;43(6):589-94. doi: 10.1016/j.exger.2008.02.004. Epub 2008 Feb 21.

PMID:
18359596
17.

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

Zetterberg H, Pedersen M, Lind K, Svensson M, Rolstad S, Eckerström C, Syversen S, Mattsson UB, Ysander C, Mattsson N, Nordlund A, Vanderstichele H, Vanmechelen E, Jonsson M, Edman A, Blennow K, Wallin A.

J Alzheimers Dis. 2007 Nov;12(3):255-60.

PMID:
18057559
18.

Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.

Fiala M, Cribbs DH, Rosenthal M, Bernard G.

J Alzheimers Dis. 2007 Jul;11(4):457-63. Review.

PMID:
17656824
19.

[Immunologic tolerance of anti-Abeta antibody in the sera of AD patients].

Yang ZY, Wang HQ, Xu J, Xie Y, Yuan QF, Yao ZB.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Oct;23(10):929-31. Chinese.

PMID:
17908502
20.

High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.

Güntert A, Döbeli H, Bohrmann B.

Neuroscience. 2006 Dec 1;143(2):461-75. Epub 2006 Sep 27.

PMID:
17008022

Supplemental Content

Support Center